Related Experiment Video
Updated: Jun 2, 2026

10:24
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
A prospective study of reticular macular disease
Nicole M Pumariega1, R Theodore Smith, Mahsa A Sohrab
1Department of Ophthalmology, Harkness Eye Institute, Columbia University, New York, New York, USA.
Ophthalmology
|May 10, 2011
Summary
Reticular pseudodrusen (RPD) significantly increases the risk of developing advanced age-related macular degeneration (AMD). This prospective study confirms RPD, a sign of reticular macular disease (RMD), is a high-risk factor for AMD progression.
Area of Science:
- Ophthalmology
- Medical Imaging
- Retinal Diseases
Background:
- Age-related macular degeneration (AMD) is a leading cause of vision loss.
- Reticular pseudodrusen (RPD) are an imaging finding associated with reticular macular disease (RMD).
- The risk of progression conferred by RPD in high-risk eyes is not fully understood.
Purpose of the Study:
- To determine the risk of progression to advanced AMD in fellow eyes with RPD.
- To assess RPD as an imaging presentation of RMD.
- To evaluate progression in high-risk eyes of subjects with unilateral choroidal neovascularization (CNV).
Main Methods:
- A prospective cohort study of 271 subjects with AMD.
- Analysis of fellow eyes at high risk for advanced AMD.
- Imaging included color, red-free, blue-light photography, and fluorescein angiography over 3 years.
- Eyes were assessed for RPD and progression to advanced AMD (CNV or geographic atrophy).
Main Results:
- Eyes with RPD showed a significantly higher rate of advanced AMD (56%) compared to eyes without RPD (32%).
- The relative risk of advanced AMD in eyes with RPD was 1.8 (95% CI, 1.4-2.4).
- Women with RPD had more than double the risk of developing advanced AMD compared to women without RPD.
Conclusions:
- Reticular macular disease (RMD), characterized by RPD, is associated with a high risk of progression to advanced AMD.
- This is the first prospective study to confirm RMD as a distinct clinical phenotype with significant AMD progression risk.
- RMD may warrant wider clinical recognition due to its association with AMD progression, potentially on an inflammatory or vascular basis.
